£1.5M
The funding round was led by the Development Bank of Wales to advance first-in-human studies.
Halo Therapeutics
Halo Therapeutics develops an antiviral spray treatment for coronaviruses.
£1.5MTotal raised
Halo Therapeutics develops an easy-to-use respiratory antiviral spray designed to prevent coronaviruses from entering and multiplying in human cells.
Filed accounts
Employees
Members only
Cash, assets and headcount from Halo Therapeutics's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
DF
Daniel Fitzgerald
CEO
CS
Christiane Schaffitzel
Professor
Imre Berger
Professor
Imre serves as a professor at Halo Therapeutics and founding director of the Max Planck Centre for Minimal Biology at the University of Bristol. He also directs the BrisSynBio Centre for Synthetic Biology and acts as an ERC Investigator.
LinkedIn